Unfer V

No ORCID on file · 5 papers in corpus
other 2025
A retrospective study "myo-inositol is a cost-saving strategy for controlled ovarian stimulation in non-polycystic ovary syndrome art patients."
Health economics review ·doi:10.1186/s13561-025-00609-8

BACKGROUND: Fertility care represents a financial burden on patients and healthcare services alike and can represent a barrier to entry for many couples. Controlled ovarian stimulation (COH) is routinely used as part of in vitro fertilizati…

other 2025
Editorial: Reviews in obstetrics and gynecology 2024
Frontiers in medicine ·doi:10.3389/fmed.2025.1661240
observational 2024
Effects of Low Luteinizing Hormone Serum Levels on Oocyte Retrieval, Fertilization Rate, and Embryo Quality during Controlled Ovarian Stimulation: Results from a Prospective Cohort Analysis
Gynecologic and obstetric investigation ·doi:10.1159/000534860

OBJECTIVES: Luteinizing hormone (LH) plays a key role in normal follicular development and oocyte maturation in controlled ovarian stimulation. LH stimulates the proliferation and differentiation of theca cells for the secretion of androgen…

review 2024
d-Chiro-Inositol in Clinical Practice: A Perspective from the Experts Group on Inositol in Basic and Clinical Research (EGOI)
Gynecologic and obstetric investigation ·doi:10.1159/000536081

BACKGROUND: d-Chiro-inositol is a natural molecule that, in association with its well-studied isomer myo-inositol, may play a role in treating various metabolic and gynecological disorders. OBJECTIVES: This perspective seeks to explore the…

review 2022
Unopposed estrogens: current and future perspectives
European review for medical and pharmacological sciences ·doi:10.26355/eurrev_202204_28629

Estrogens and progestogens act on female reproductive tissues in opposite ways. As they counteract each other actions, the correct balance between these two classes of hormones is pivotal to avoid dangerous states. Unopposed estrogens occur…